Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.82 USD | +1.50% |
|
+19.03% | -21.67% |
06-27 | INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer's Disease Trial | CI |
05-30 | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Neutral |
Resistance | 9.080 | 9.920 | 14.01 |
Spread/Res. | -2.86% | -11.09% | -37.04% |
Spread/Supp. | +23.36% | +23.36% | +30.86% |
Support | 7.150 | 7.150 | 6.740 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- INMB Stock
- Charts INmune Bio, Inc.